RA
Ruchi Amit Rajan
About Ruchi Amit Rajan
Data last updated:
Ruchi Amit Rajan is a Director at Prosfora Technologies Private Limited (since 2015), Director at Bioture Labs Private Limited (since 2021) and Nominee Director at Tooba Pharmaceuticals Private Limited (since 2025). The companies operate in Pharma and Travel and Hospitality. The 3 current companies with reported revenue have a combined latest revenue of ₹129 Cr; the largest is Prosfora Technologies Private Limited at ₹125 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Mar 2015 | 2015 | ₹125 Cr (FY 2025) | Active | |
| Director | 15 Jan 2021 | 2013 | ₹2.54 Cr (FY 2025) | Active | |
| Nominee Director | 06 Dec 2025 | 2008 | ₹1.97 Cr (FY 2024) | Active |
Board colleagues of Ruchi Amit Rajan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Rajan | 03264797 | Prosfora Technologies Private Limited | Director |
| Amitkumar Kantibhai Prajapati | 06925850 | Bioture Labs Private Limited | Director |
| Mohammed Jaweed Mukarram Siddiqui | 02033913 | Tooba Pharmaceuticals Private Limited | Director |
| Rizwana Khanum | 02086864 | Tooba Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ruchi Amit Rajan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ruchi Amit Rajan
Ruchi Amit Rajan currently holds 3 directorships: Prosfora Technologies Private Limited (Director, since 30 Mar 2015, revenue ₹125 Cr (FY 2025)); Bioture Labs Private Limited (Director, since 15 Jan 2021, revenue ₹2.54 Cr (FY 2025)); Tooba Pharmaceuticals Private Limited (Nominee Director, since 06 Dec 2025, revenue ₹1.97 Cr (FY 2024)).
Ruchi Amit Rajan was first appointed on 30 Mar 2015 as Director at Prosfora Technologies Private Limited. The most recent appointment on record is 06 Dec 2025 at Tooba Pharmaceuticals Private Limited.
The 3 current companies of Ruchi Amit Rajan that report revenue have a combined latest revenue of ₹129 Cr: Prosfora Technologies Private Limited ₹125 Cr (FY 2025); Bioture Labs Private Limited ₹2.54 Cr (FY 2025); Tooba Pharmaceuticals Private Limited ₹1.97 Cr (FY 2024).
The current boards of Ruchi Amit Rajan's companies include Amit Rajan (Prosfora Technologies Private Limited), Amitkumar Kantibhai Prajapati (Bioture Labs Private Limited), Mohammed Jaweed Mukarram Siddiqui (Tooba Pharmaceuticals Private Limited), Rizwana Khanum (Tooba Pharmaceuticals Private Limited).